Zobrazeno 1 - 10
of 4 490
pro vyhledávání: '"De Smedt T"'
Autor:
Pejoski, D., Suess, C., Gouiller, A., Héritier, M., Boujut, M., Tardy, S., De Smedt, T., Galibert, L., Reith, W., Joerger, M., Toso, C., Kössler, T., Hamed, H., Scapozza, L.
Publikováno v:
In Immuno-Oncology and Technology December 2023 20 Supplement
Autor:
de Jong AJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., van Rijssel TI; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Zuidgeest MGP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Thiel GJMW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Askin S; Regulatory Affairs Innovation, Novartis Pharma AG, Basel, Switzerland., Fons-Martínez J; The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., De Smedt T; Global Regulatory Affairs, UCB Pharma, Brussels, Belgium., de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Santa-Ana-Tellez Y; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Aug; Vol. 112 (2), pp. 344-352. Date of Electronic Publication: 2022 May 17.
Autor:
Gorce, Philippe1,2 (AUTHOR) gorce@univ-tln.fr, Jacquier-Bret, Julien1,2 (AUTHOR) jacquier@univ-tln.fr
Publikováno v:
Bioengineering (Basel). Oct2024, Vol. 11 Issue 10, p974. 23p.
Autor:
Vasquez, Holland M.1 (AUTHOR), Pianarosa, Emilie2 (AUTHOR), Sirbu, Renee2 (AUTHOR), Diemert, Lori M.2 (AUTHOR), Cunningham, Heather3 (AUTHOR), Harish, Vinyas2,4 (AUTHOR), Donmez, Birsen1 (AUTHOR), Rosella, Laura C.2,4,5 (AUTHOR) laura.rosella@utoronto.ca
Publikováno v:
BMC Public Health. 9/10/2024, Vol. 24 Issue 1, p1-15. 15p.
Autor:
Hao, Zhipeng1 (AUTHOR) hz.peng@stu.qau.edu.cn, Dong, Xufeng1 (AUTHOR), Zhang, Zhongtao1 (AUTHOR), Qin, Zhihua1 (AUTHOR) qinzhihua@qau.edu.cn
Publikováno v:
Biomolecules (2218-273X). Sep2024, Vol. 14 Issue 9, p1116. 13p.
Publikováno v:
Canadian Journal of Human Sexuality. Sep2024, Vol. 33 Issue 2, p172-186. 15p.
Autor:
Monti, Federico1 (AUTHOR) federico.monti15@studio.unibo.it, Perazza, Federica1 (AUTHOR) federica.perazza@studio.unibo.it, Leoni, Laura2 (AUTHOR) leoni_laura@hotmail.it, Stefanini, Bernardo1,3 (AUTHOR) bernardo.stefanini@unibo.it, Ferri, Silvia3 (AUTHOR), Tovoli, Francesco1,3 (AUTHOR) francesco.tovoli@unibo.it, Zavatta, Guido1,4 (AUTHOR) guido.zavatta@unibo.it, Piscaglia, Fabio1,3 (AUTHOR) fabio.piscaglia@unibo.it, Petroni, Maria Letizia1,5 (AUTHOR) marialetizia.petroni@unibo.it, Ravaioli, Federico1,3 (AUTHOR) f.ravaioli@unibo.it
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9193. 15p.
Autor:
Suri, Misty1 msuri@ochsner.org, Grilliot, Jordan1, Verma, Arjun2, Renshaw, Andrew1, Jones, Deryk1,3, Finger, Simon4
Publikováno v:
Ochsner Journal. Sep2024, Vol. 24 Issue 3, p207-212. 6p.
Autor:
Bollaerts K; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: kaatje.bollaerts@p-95.com., de Smedt T; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: tom.desmedt@p-95.com., McGee C; Royal College of General Practitioners Research and Surveillance Centre, London, UK; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK. Electronic address: c.mcgee@surrey.ac.uk., Emborg HD; Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark. Electronic address: HDE@ssi.dk., Villa M; ATS della Val Padana, Cremona, Italy. Electronic address: marco.villa@ats-valpadana.it., Alexandridou M; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium. Electronic address: maria.alexandridou@p-95.com., Duarte-Salles T; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Electronic address: tduarte@idiapjgol.org., Gini R; Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy. Electronic address: rosa.gini@ars.toscana.it., Bartolini C; Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy. Electronic address: claudia.bartolini@ars.toscana.it., de Lusignan S; Royal College of General Practitioners Research and Surveillance Centre, London, UK; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK. Electronic address: s.lusignan@surrey.ac.uk., Tin Tin Htar M; Pfizer, 23-25 Avenue du Dr Lannelongue, 75014 Paris, France. Electronic address: myint.tintinhtar@pfizer.com., Titievsky L; Pfizer, 219 East 42nd St, NY, NY 10017, USA. Electronic address: lina.titievsky@pfizer.com., Sturkenboom M; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan 1, 3001 Heverlee, Belgium; Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands; VACCINE.GRID Foundation, Basel, Switzerland. Electronic address: miriam.sturkenboom@p-95.com., Bauchau V; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: vincent.g.bauchau@gsk.com.
Publikováno v:
Vaccine [Vaccine] 2020 Dec 22; Vol. 38 Suppl 2, pp. B76-B83. Date of Electronic Publication: 2019 Oct 31.
Autor:
Bollaerts K; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium. Electronic address: kaatje.bollaerts@p-95.com., Ledent E; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: edouard.y.ledent@gsk.com., de Smedt T; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium. Electronic address: tom.desmedt@p-95.com., Weibel D; Erasmus University Medical Center, Post box 2040, 3000 CA Rotterdam, the Netherlands; VACCINE.GRID, Spitalstrasse 33, Basel, Switzerland. Electronic address: d.weibel@erasmusmc.nl., Emborg HD; Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark. Electronic address: HDE@ssi.dk., Danieli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy., Duarte-Salles T; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Electronic address: tduarte@idiapjgol.org., Huerta-Alvarez C; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP), Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: chuerta@aemps.es., Martín-Merino E; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP), Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: emartinm@aemps.es., Picelli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy. Electronic address: g.picelli@virgilio.it., Tramontan L; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy. Electronic address: ltramontan@consorzioarsenal.it., Sturkenboom M; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium; VACCINE.GRID, Spitalstrasse 33, Basel, Switzerland; Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: miriam.sturkenboom@p-95.com., Bauchau V; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: vincent.g.bauchau@gsk.com.
Publikováno v:
Vaccine [Vaccine] 2020 Dec 22; Vol. 38 Suppl 2, pp. B65-B75. Date of Electronic Publication: 2019 Oct 31.